Neuroimaxe e Biotecnoloxía
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublications in collaboration with researchers from GlaxoSmithKline (United Kingdom) (1)
2005
-
Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia
Neurobiology of Disease, Vol. 18, Núm. 2, pp. 375-384